Krka Reaches EUR 500m in Sales in Q3, Profit Up 28%

Ljubljana, 16 November - Pharma company Krka saw a continuation in strong sales in the third quarter of this year. The company reported on Thursday sales revenues of SIT 120bn (EUR 500m) for the first three quarters of the year, which is 23% more than in the same period last year. The group's net profit was up 28% at SIT 19bn (EUR 79.3m) in the same period.